Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun
R
R
Service d'Hematologie, Hôtel Dieu, Paris, France.
Liso
V
V
Mandelli
F
F
Rotoli
B
B
de Witte
T
T
Gattringer
C
C
Resegotti
L
L
Caronia
F
F
Leoni
P
P
Petti
M C
MC
D000206:Actuarial Analysis; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007558:Italy; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
D000677:Amsacrine; D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin